Home › Funds › DAFNA Capital Management LLC › ALLO

DAFNA Capital Management LLC position in ALLO

ALLOGENE THERAPEUTICS INC · Health Care

DAFNA Capital Management LLC reported holding 2,000,000 shares of ALLO (ALLOGENE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$4.2M, representing 0.79% of its reported portfolio and ranking #29 among its reported holdings. DAFNA Capital Management LLC has disclosed ALLO holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)2.00M sh
Reported value held$4.16M
Portfolio Weight0.79%
First reportedQ2 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How DAFNA Capital Management LLC's ALLO position evolved

DAFNA Capital Management LLC first disclosed a stake in ALLO in Q2 2024 at 605,100 shares (US$1.4M). The position peaked in Q2 2026 at 2,000,000 shares, worth US$4.2M. Across 9 filings, DAFNA Capital Management LLC increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 2,000,000 shares valued at US$4.2M — an increase of 629,882 shares quarter over quarter.. Notable position changes include a 74% increase in Q3 2024 (shares fell 24% over the following quarter), a 46% increase in Q2 2026 (shares fell 23% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 605.10K $1.41M New
Q3 2024 1.05M $2.94M Add
Q4 2024 1.24M $2.64M Add
Q1 2025 1.38M $2.01M Add
Q2 2025 1.38M $1.56M Hold
Q3 2025 1.38M $1.71M Hold
Q4 2025 1.38M $1.89M Hold
Q1 2026 1.37M $3.34M Reduce
Q2 2026 2.00M $4.16M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ALLO and 13F data

ALLO (ALLOGENE THERAPEUTICS INC) is a Health Care company. 44 other funds we track also report a position in ALLO — the largest reported positions include PFIZER INC (US$46.9M), Frazier Life Sciences Management, L.P. (US$46.7M), TPG GP A, LLC (US$38.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ALLO

All ALLO fund holders →

FAQ

How long has DAFNA Capital Management LLC held ALLO?

DAFNA Capital Management LLC has disclosed ALLO holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

What is DAFNA Capital Management LLC's current position in ALLO?

As of Q2 2026, DAFNA Capital Management LLC holds 2.00M shares of ALLO (ALLOGENE THERAPEUTICS INC), valued at $4.16M, representing 0.79% of its reported portfolio and ranking #29.

Has DAFNA Capital Management LLC been buying or selling ALLO?

In the latest 13F filing (Q2 2026), DAFNA Capital Management LLC increased its position in ALLO. The position peaked in Q2 2026 at 2.00M shares.

Which other funds hold ALLO?

Other major institutional holders of ALLO include PFIZER INC, Frazier Life Sciences Management, L.P., TPG GP A, LLC, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.